News Conference News TCT 2024 ECLIPSE: Orbital Atherectomy No Better Than Balloon Angioplasty in Calcified Lesions Yael L. Maxwell October 29, 2024
News Opinion Editor's Corner TCT 2024 What’s Going to Be Big at TCT 2024? Michael O'Riordan October 17, 2024
News Daily News Varipulse Pulsed-Field Ablation System Safe, Effective in Pivotal Trial Todd Neale September 30, 2024
News Conference News ESC 2024 ‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS Michael O'Riordan September 09, 2024
News Daily News DES Best for In-Stent Restenosis, but DCBs Also Viable Michael O'Riordan August 13, 2024
News Conference News EuroPCR 2024 Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT Michael O'Riordan May 28, 2024
News Conference News EuroPCR 2024 OCT-Based Strategy Outperforms Angiography in Calcified Lesions: CALIPSO Caitlin E. Cox May 16, 2024
News Conference News SCAI 2024 No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis L.A. McKeown May 10, 2024
News Daily News As US Rollout Begins for Coronary DCBs, Interventionalists Mull Practice Changes Todd Neale May 03, 2024
News Industry News Concept Medical Announces Enrollment of First Patient in “Magical-ISR” IDE Study in the US April 19, 2024
News Daily News Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI Michael O'Riordan March 26, 2024
News Daily News QCA an Alternative to IVUS? GUIDE-DES Trial Hints at the Possibility Caitlin E. Cox March 20, 2024
News Daily News Pay Now, Save Later: Intracoronary Imaging for PCI Cost-effective Over Lifetime Yael L. Maxwell March 18, 2024
News Daily News Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis L.A. McKeown March 01, 2024
News Daily News TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable Michael O'Riordan January 09, 2024
News Conference News TCT 2023 Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis Todd Neale November 02, 2023
News Conference News TCT 2023 Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80 Michael O'Riordan November 01, 2023